Semin Reprod Med 2008; 26(1): 035-038
DOI: 10.1055/s-2007-992922
© Thieme Medical Publishers

Does Polycystic Ovary Syndrome Increase the Disparity in Metabolic Syndrome and Cardiovascular-Related Health for African-American Women?

PonJola Coney1 , 3 , Gwinnett Ladson1 , Stephanie Sweet1 , Richard S. Legro2
  • 1Department of Obstetrics & Gynecology, Meharry Medical College, Nashville, Tennessee
  • 2Penn State College of Medicine, Hershey, Pennsylvania
  • 3Current affiliation: Department of Obstetrics & Gynecology, Virginia Commonwealth University, Richmond, Virginia
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. Januar 2008 (online)

ABSTRACT

There have been few formal studies of differences in the phenotype of PCOS among women of African-American ancestry. Generally, African-American women tend to have an adverse cardiovascular risk profile when compared with women of other racial groups. The metabolic syndrome is a clinical disorder that identifies individuals at risk for diabetes and cardiovascular disease. Preliminary studies support that both African-American and White women with PCOS have similar prevalences of the metabolic syndrome, suggesting that the diagnosis may not be associated with racial differences in cardiovascular risk factors.

REFERENCES

  • 1 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.  Fertil Steril. 2004;  81 19-25
  • 2 Dunaif A. Insulin action in the polycystic ovary syndrome.  Endocrinol Metab Clin North Am. 1999;  28 341-359
  • 3 Dunaif A. Current concepts in the polycystic ovary syndrome.  Annu Rev Med. 2001;  52 401-419
  • 4 Moller D E, Kaufman K D. Metabolic syndrome: a clinical and molecular perspective.  Annu Rev Med. 2005;  56 45-62
  • 5 Knochenhauer E S, Key T J, Kahsar-Miller M, Waggoner W, Boots L R, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.  J Clin Endorinol Metab. 1998;  83 3078-3082
  • 6 Hoyert D L, Heron M P, Murphy S L, Kung H C. Deaths: final data for 2003.  Natl Vital Stat Rep. 2006;  54 1-120
  • 7 Institute of Medicine .Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC; National Academy of Sciences 2002
  • 8 Mensah G A, Mokdad A H, Ford E S, Greenlund K J, Croft J B. State of disparities in cardiovascular health in the United States.  Circulation. 2005;  111 1233-1241
  • 9 Finkelstein E A, Khavjou M A, Mobley L R, Haney D M, Will J C. Racial/ethic disparities in coronary heart disease risk factors among WISEWOMAN enrollees.  J Womens Health. 2004;  13 503-518
  • 10 Welt C K, Arason G, Gudmundsson J A et al.. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.  J Clin Endocrinol Metab. 2006;  91 4361-4368
  • 11 Dokras A, Bochner M, Hollinrake E, Markham S, VanVoorhis B, Jagasia D H. Screening women with polycystic ovary syndrome for metabolic syndrome.  Obstet Gynecol. 2005;  106 131-137
  • 12 Legro R S, Myers E R, Barnhart H X et al. for the the Reproductive Medicine Network. . The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects.  Fertil Steril. 2006;  86 914-933
  • 13 Carnethon M R, Loria C M, Hill J O, Sidney S, Savage P J, Liu K. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (Cardia) study, 1985-2001.  Diabetes Care. 2004;  27 2707
  • 14 Coviello A D, Legro R S, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.  J Clin Endocrinol Metab. 2006;  91 492-497
  • 15 Ehrmann D A, Liljenquist D R, Kasza K, Azziz R, Legro R S, Ghazzi M N. for the PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with PCOS.  J Clin Endocrinol Metab. 2006;  91 48-53
  • 16 Holte J, Bergh T, Berne C et al.. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 1995;  80 2586-2593
  • 17 Palaniappan L P, Kwan A C, Abbasi F, Lamendola C, McLaughlin T L, Reaven G M. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.  Metabolism. 2007;  56 899-904
  • 18 Chen M J, Yang W S, Yang J H, Chen C L, Ho H N, Yang Y S. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.  Hypertension. 2007;  49 1442-1447

PonJola ConeyM.D. 

Department of Obstetrics & Gynecology, Virginia Commonwealth University

1101 E. Marshall St., Richmond, VA 23208

eMail: pconey@vcu.edu